AGA Research Foundation Announces Endowment Gift From Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
5/14/2013 9:33:21 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
5/2/2013 8:13:39 AM
More...
|
Takeda Pharmaceuticals Loses Cancer Suit Over Actos
4/29/2013 8:09:12 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Actos Diabetes Drug Tied to Cancer, Jury is Told
4/16/2013 7:34:41 AM
More...
|
The Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
3/13/2013 9:47:29 AM
More...
|
Takeda Pharmaceuticals' Alogliptin Wins FDA Approval
2/8/2013 11:00:30 AM
More...
|
The New England Journal of Medicine Publishes Pivotal Trial Data for Affymax, Inc. (AFFY), and Takeda Pharmaceuticals's OMONTYS® (peginesatide) Injection for Treatment of Anemia in Adult Chronic Kidney Disease Patients on Hemodialysis
1/24/2013 9:01:03 AM
More...
|
Affymax, Inc. (AFFY) and Takeda Pharmaceuticals Announce Permanent J-Code for OMONTYS® (peginesatide) Injection is in Effect
1/3/2013 9:49:13 AM
More...
|
Takeda Pharmaceuticals, Amylin Pharmaceuticals, Inc. (AMLN) Terminate $1 Billion Anti-Obesity Pact
12/27/2012 7:46:03 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Opens China Clinical Trial Center in Shanghai
8/10/2012 11:17:51 AM
More...
|
|